161
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Prevalence and Predictors of Hypovitaminosis D in Ethiopian HIV-Infected Adults

ORCID Icon, , ORCID Icon, , ORCID Icon & ORCID Icon
Pages 1101-1109 | Published online: 22 Dec 2021

References

  • Dao CN, Patel P, Overton ET, et al. Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population. Clin Infect Dis. 2011;52(3):396–405. doi:10.1093/cid/ciq158
  • Kim JH, Gandhi V, Psevdos G, Espinoza F, Park J, Sharp V. Evaluation of vitamin D levels among HIV-infected patients in New York city. AIDS Res Hum Retroviruses. 2012;28(3):235–241. doi:10.1089/aid.2011.0040
  • Crutchley RD, Gathe J, Mayberry C, Trieu A, Abughosh S, Garey KW. Risk factors for vitamin D deficiency in HIV-infected patients in the south central United States. AIDS Res Hum Retroviruses. 2012;28(5):454–459. doi:10.1089/aid.2011.0025
  • Cervero M, Agud JL, García-Lacalle C, et al. Prevalence of vitamin D deficiency and its related risk factor in a Spanish cohort of adult HIV-infected patients: effects of antiretroviral therapy. AIDS Res Hum Retroviruses. 2012;28(9):963–971. doi:10.1089/aid.2011.0244
  • Ezeamama AE, Guwatudde D, Wang M, et al. Vitamin-D deficiency impairs CD4+T-cell count recovery rate in HIV-positive adults on highly active antiretroviral therapy: a longitudinal study. Clin Nutr. 2016;35(5):1110–1117. doi:10.1016/j.clnu.2015.08.007
  • Saccomanno MF, Ammassari A. Bone disease in HIV infection. Clin Cases Miner Bone Metab. 2011;8(1):33–36.
  • Premaor MO, Compston JE. The hidden burden of fractures in people living with HIV. JBMR Plus (WOA). 2018;2(5):247–256. doi:10.1002/jbm4.10055
  • Lai H, Fishman EK, Gerstenblith G, et al. Vitamin D deficiency is associated with development of subclinical coronary artery disease in HIV-infected African American cocaine users with low Framingham-defined cardiovascular risk. Vasc Health Risk Manag. 2013;9:729–737. doi:10.2147/VHRM.S50537
  • Cheru LT, Saylor CF, Fitch KV, et al. Low vitamin D is associated with coronary atherosclerosis in women with HIV. Antivir Ther. 2019;24(7):505–512. doi:10.3851/IMP3336
  • Calza L, Borderi M, Granozzi B, et al. Vitamin D insufficiency is associated with subclinical atherosclerosis in HIV-1-infected patients on combination antiretroviral therapy. HIV Res Clin Pract. 2019;20(6):131–139. doi:10.1080/25787489.2020.1724749
  • Portilla J, Moreno-Pérez O, Serna-Candel C, et al. Vitamin D insufficiency and subclinical atherosclerosis in non-diabetic males living with HIV. J Int AIDS Soc. 2014;17(1):18945. doi:10.7448/IAS.17.1.18945
  • Alvarez JA, Ashraf A. Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol. 2010;2010:351385. doi:10.1155/2010/351385
  • Vergori A, Pinnetti C, Lorenzini P, et al. Vitamin D deficiency is associated with neurocognitive impairment in HIV-infected subjects. Infection. 2019;47(6):929–935. doi:10.1007/s15010-019-01313-6
  • Sudfeld CR, Mugusi F, Muhihi A, et al. Efficacy of vitamin D(3) supplementation for the prevention of pulmonary tuberculosis and mortality in HIV: a randomised, double-blind, placebo-controlled trial. Lancet HIV. 2020;7(7):e463–e471. doi:10.1016/S2352-3018(20)30108-9
  • Sudfeld CR, Mugusi F, Aboud S, Nagu TJ, Wang M, Fawzi WW. Efficacy of vitamin D(3) supplementation in reducing incidence of pulmonary tuberculosis and mortality among HIV-infected Tanzanian adults initiating antiretroviral therapy: study protocol for a randomized controlled trial. Trials. 2017;18(1):66. doi:10.1186/s13063-017-1819-5
  • Hidron AI, Hill B, Guest JL, Rimland D. Risk factors for vitamin D deficiency among veterans with and without HIV infection. PLoS One. 2015;10(4):e0124168. doi:10.1371/journal.pone.0124168
  • Avihingsanon A, Kerr SJ, Ramautarsing RA, et al. The association of gender, age, efavirenz use, and hypovitaminosis D among HIV-infected adults living in the tropics. AIDS Res Hum Retroviruses. 2016;32(4):317–324. doi:10.1089/aid.2015.0069
  • Madeddu G, Spanu A, Solinas P, et al. Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy. Q J Nucl Med Mol Imaging. 2004;48(1):39–48.
  • Missailidis C, Höijer J, Johansson M, et al. Vitamin D status in well‐controlled caucasian HIV patients in relation to inflammatory and metabolic markers–a cross‐sectional cohort study in Sweden. Scand J Immunol. 2015;82(1):55–62. doi:10.1111/sji.12299
  • Theodorou M, Sersté T, Van Gossum M, Dewit S. Factors associated with vitamin D deficiency in a population of 2044 HIV-infected patients. Clin Nutr. 2014;33(2):274–279. doi:10.1016/j.clnu.2013.04.018
  • World Health Organization. Obesity: preventing and managing the global epidemic; 2000.
  • Allavena C, Delpierre C, Cuzin L, et al. High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs. J Antimicrob Chemother. 2012;67(9):2222–2230. doi:10.1093/jac/dks176
  • Bearden A, Abad C, Gangnon R, Sosman JM, Binkley N, Safdar N. Cross-sectional study of vitamin D levels, immunologic and virologic outcomes in HIV-infected adults. J Clin Endocrinol Metab. 2013;98(4):1726–1733. doi:10.1210/jc.2012-4031
  • Wiboonchutikul S, Sungkanuparph S, Kiertiburanakul S, et al. Vitamin D insufficiency and deficiency among HIV-1-infected patients in a tropical setting. J Int Assoc Provid AIDS Care. 2012;11(5):305–310. doi:10.1177/1545109711432142
  • Deshwal R, Arora S. High prevalence of vitamin D deficiency in HIV infected on antiretroviral therapy in a cohort of Indian patients. J Assoc Physicians India. 2019;67(3):42–45.
  • Poowuttikul P, Thomas R, Hart B, Secord E. Vitamin D insufficiency/deficiency in HIV-infected inner city youth. J Int Assoc Provid AIDS Care. 2014;13(5):438–442. doi:10.1177/2325957413495566
  • Klassen KM, Fairley CK, Kimlin MG, Hocking J, Kelsall L, Ebeling PR. Vitamin D deficiency is common in HIV-infected southern Australian adults. Antivir Ther. 2016;21(2):117–125. doi:10.3851/IMP2983
  • Vescini F, Cozzi-Lepri A, Borderi M, et al. Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort. J Acquir Immune Defic Syndr. 2011;58(2):163–172. doi:10.1097/QAI.0b013e31822e57e9
  • Jao J, Freimanis L, Mussi-Pinhata MM, et al. Low vitamin D status among pregnant Latin American and Caribbean women with HIV Infection. Int J Gynaecol Obstet. 2015;130(1):54–58. doi:10.1016/j.ijgo.2015.01.017
  • Nugmanova ZS, Patel N, Akhmetova GM, et al. Relationship between vitamin D and human immunodeficiency virus (HIV) viral load among HIV-infected patients in Kazakhstan. J Infect Dev Ctries. 2015;9(11):1277–1283. doi:10.3855/jidc.6808
  • Sudfeld CR, Wang M, Aboud S, Giovannucci EL, Mugusi FM, Fawzi WW. Vitamin D and HIV progression among Tanzanian adults initiating antiretroviral therapy. PLoS One. 2012;7(6):e40036. doi:10.1371/journal.pone.0040036
  • Kagotho E, Omuse G, Okinda N, Ojwang P. Vitamin D status in healthy black African adults at a tertiary hospital in Nairobi, Kenya: a cross sectional study. BMC Endocr Disord. 2018;18(1):1–7. doi:10.1186/s12902-018-0296-5
  • Tangoh DA, Apinjoh TO, Mahmood Y, et al. Vitamin D status and its associated risk factors among adults in the Southwest region of Cameroon. J Nutr Metab. 2018;2018:1–9. doi:10.1155/2018/4742574
  • Khadilkar SS. The emerging role of vitamin D3 in women’s health. J Obstet Gynaecol India. 2013;63(3):147–150. doi:10.1007/s13224-013-0420-4